Clinical Research Management/Coordinator, Nurse Practitioner, RN
Resume:
NICOLE COFER, ANP, RN, MS
**** ******** **** **********, ** 23323
US Phone: 757-***-****
Email: adjegd@r.postjobfree.com
OBJECTIVE:
Experienced and talented clinical professional with excellent research skills and familiarity with investigative clinical studies. Desirous of a Clinical Research position in Medical practice or an Academic Center. Coming with strong planning and prioritization skills, superior administrative skills, and great communication skills. Seeking to utilize 6 years of clinical research experience as a Clinical Research Coordinator, Supervisor, and Sub-Investigator. Coming with exceptional organizational skills and Certification in Good Clinical Practice. Offering strong knowledge of GCP/ICH, FDA and local guidelines, MS degree and leadership skills.
EDUCATION AND TRAINING:
THE OHIO STATE UNIVERSITY, Columbus, OH
Masters, Clinical Research/Clinical Research Management Degree date: Expected December 2020
THE OHIO STATE UNIVERSITY, Columbus, OH
Masters, Adult Health and Illness Nurse Practitioner Degree date: March 2001
THE OHIO STATE UNIVERSITY, Columbus, OH
Baccalaureate, Science of Nursing
Degree date: June 1997
EMPLOYMENT HISTORY:
FAMILY MEDICAL PRACTITIONERS
February 2019- November 2019
Adult and Pediatric Nurse Practitioner in Psychiatry
● initial evaluations of geriatric, adult, adolescent, and children with psychiatric conditions that include ADHD, Bipolar, Anxiety and Panic Disorders, PTSD, Depression, Schizophrenia, and Sleep Disturbances
● medication management for follow up patients
HAMPTON MEDICAL HEALTH ASSOCIATES, Hampton, VA
March 2017-May 2017
Adult Nurse Practitioner in Psychiatry
● initial evaluations of geriatric, adult, adolescent, and children with psychiatric conditions that include ADHD, Bipolar, Anxiety and Panic Disorders, PTSD, Depression, Schizophrenia, and Sleep Disturbances
● medication management for follow up patients
QUIETLY RADIANT PSYCHIATRIC SERVICES, Virginia Beach, VA May 2016- September 2016
Adult and Pediatric Nurse Practitioner in Psychiatry
● initial evaluations of geriatric, adult, adolescent, and children with psychiatric conditions that include ADHD, Bipolar, Anxiety and Panic Disorders, PTSD, Depression, Schizophrenia, and Sleep Disturbances
● medication management for follow up patients
● order and evaluate Combinatorial Genetic Testing FAIRFIELD PSYCHOLOGICAL ASSOCIATES, Virginia Beach, VA November 2015- May 2016
Adult and Pediatric Nurse Practitioner in Psychiatry
● initial evaluations of geriatric, adult, adolescent, and children with psychiatric conditions that include ADHD, Bipolar, Anxiety and Panic Disorders, PTSD, Depression, Schizophrenia, and Sleep Disturbances
● medication management for follow up patients
● order and evaluate Combinatorial Genetic Testing PARKER AND SCHLICHTER ASSOCIATES, Virginia Beach, VA December 2012 — September 2015
Adult and Pediatric Nurse Practitioner in Psychiatry
● provided medication management for patients with acute and chronic psychiatric illness
● ordered diagnostic testing for comprehensive treatment/care of the patient SENTARA MEDICAL GROUP, Virginia Beach, VA
July 2009 — July 2012
Adult Nurse Practitioner and Research Sub-Investigator
● provided follow-up patient care in the neurology division with a sub-specialty in Movement Disorders
● Sub-Investigator for clinical trials for Parkinson's Disease patients
● Performed Deep Brain Stimulation programming
● Documented and successfully applied findings of patient data encompassing assessment, results, interventions, medications, patient responses and treatment changes.
● Patient/family education, and Interdisciplinary care THE OHIO STATE UNIVERSITY MEDICAL CENTER, Columbus, OH July 2006 — June 2009
Adult Nurse Practitioner and Research Coordinator/Supervisor
● Provided emergency patient care and follow-up visits in the Movement Disorder Division
● Developed treatment plans adhering to rigorous standards of care and professional practice guidelines.
● Performed Deep Brain Stimulation programming
● Research Supervisor in clinical trials for Parkinson's Disease patients.
● Patient/family education
● Staff training and evaluations
CENTRAL OHIO PRIMARY CARE PHYSICIANS, Columbus, OH July 2002 — January 2006
Adult Nurse Practitioner
● Demonstrated expertise in supporting patients with multiple chronic co-morbidities, including diagnosing, treating and initiating medication, performing diagnostic interventions, and executing follow-ups as required
● Demonstrated expertise in assessing, diagnosing, examining, and providing treatment plans for patients with acute illnesses
MOUNT CARMEL WEST MEDICAL CENTER, Columbus, OH
June 2001 — July 2002
Staff Nurse, Medical Intensive Care Unit
● Intensive monitoring of critically ill patients in a nine-bed unit; providing numerous life-saving measures that include ventilator support, intravenous drips, cardiac monitoring, and ACLS measures.
THE OHIO STATE UNIVERSITY MEDICAL CENTER, Columbus, OH June 1997-June 2001
Staff Nurse, Surgical Intensive Care
● Intensive monitoring of stable and unstable patients in a 44-bed unit
● supplied medications and intravenous fluids, detailed assessments and a variety of procedures to a wide range of surgical patients including burn, neurological, trauma, cardiac, transplant and general surgery patients.
THE OHIO STATE UNIVERSITY MEDICAL CENTER, Columbus, OH December 1995 — June 1997
Student Nurse Associate
● Rehabilitation unit in Dodd Hall-vital signs, weighing patients, hygiene care, EKG's phlebotomy, tracheotomy and G-tube care, suctioning, and charting. CURRENT AND PAST RESEARCH EXPERIENCES:
Sub-Investigator - Chelsea Pharmaceuticals
June 2011 — July 2012
● A multi-centered, opened-label study to assess the long-term safety of droxidopa in subjects with primary autonomic failure, dopamine beta hydroxylase deficiency or non- diabetic neuropathy and symptomatic neurogenic orthostatic hypotension. May 2010 — July 2012
● A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to assess the clinical effect of droxidopa in the treatment of symptomatic neurogenic orthostatic hypotension in patients with Parkinson's disease. Sub-Investigator - Acadia Pharmaceuticals
September 2010-July 2012
● A multi-center, open-label extension study to examine safety and tolerability of ACP-103 in the treatment of psychosis in Parkinson's Disease.
● A Multi-Center, Placebo-Controlled, Double-Blind Trial to examine the safety and efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's disease. Sub-Investigator - Ipsen Pharmaceuticals
May 2010 — July 2012
● A randomized, double-blind, placebo-controlled, study of the efficacy and safety of Trimethobenzamide (Tigan) in the control of nausea and vomiting during initiation and treatment with continuous apomorphine (Apoken) in apomorphine-naïve subjects with Parkinson's Disease suffering from acute intermittent "off" episodes, with phased withdrawal of subjects from Tigan to placebo. Sub-Investigator - Schwarz Pharmaceuticals
February 2010 — January 2012
● SP921. A multi-center, randomized, double-blind, placebo-controlled, 5-arm, parallel- group trial to assess rotigotine transdermal system dose response in subjects with advanced-stage Parkinson's disease.
Sub-Investigator - Teva Pharmaceuticals
December 2010 — July 2012
● Andante: Add-On to Dopamine Agonists in early stage patients needing enhanced treatment efficacy.
Research Supervisor- Neurologix
January 2008 — December 2009
● Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects with Advanced Parkinson's Disease. Research Supervisor - Acadia
January 2008 — January 2009
● ACP-103-015. A multi-centered, open-labeled extension study of the safety and efficacy of ACP-103 in the treatment of psychosis in Parkinson's disease.
● ACP-103-012. A multi-centered, double-blind, Placebo-controlled Trial to Examine the Safety and Efficacy of ACP-103 (pimavanserin tartrate) in the Treatment of Psychosis in Parkinson's disease.
Research Supervisor- NIH/Parkinson’s Study Group/Weill Medical College at Cornell University January 2008 — January 2009
● QE3. A randomized, double-blind, placebo-controlled trial of Coenzyme Q10 in early Parkinson's Disease.
Research Coordinator - Schwarz Pharmaceuticals
January 2007 — January 2009
● SP 921. A multi-centered, Randomized, double-blind, placebo-controlled trial to assess rotigotine transdermal system response in subjects with advanced-stage Parkinson's disease.
Research Coordinator-LINK Medicine Corporation
January 2008 — January 2009
● LNK754. Phase-IIa. A Double-blind, placebo-controlled, randomized, multicentered, single-dose followed by multi-dosed study to explore the safety, tolerability, pharmacokinetics and pharmacodynamics of LNK-754 (a farnesyl transferase inhibitor) inpatients with early Parkinson's disease that have no disability requiring dopaminergic therapy.
Research Coordinator- PSG/Boehringer Ingelheim
January 2006 — January 2008
● PramiBID. A randomized, double-blind, active and placebo-controlled efficacy study of pramipexole given 0.5mg and 0.75 mg bid in early Parkinson's Disease. Research Coordinator - NIH/Parkinson’s Study Group January 2004 — January 2009
● Progeni: Parkinson's Research: Organized Genetics Initiative. Genetic study in siblings with Parkinson's Disease.
Research Coordinator - Eisai Pharmaceuticals
January 2007 — January 2008
● E2007-A001-303. A multi-centered, open-labeled extension study of the efficacy, safety and tolerability of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.
● E2007-A001-302. A multi-centered, randomized, double-blind, placebo-controlled, parallel group study of the efficacy, safety, and tolerability of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations. Research Coordinator- Novartis
January 2005 — January 2007
● QUEST-PD. An assessment of quality of life in Advanced PD patients with end of dose wearing off on levodopa therapy switched to Stalevo therapy. Research Coordinator-Schwarz Biosciences
January 2002 — January 2009
● A multicenter, multinational, double blind, randomized placebo-controlled trial of efficacy and safety of rotigotine, a dopamine agonist delivered by CDA patch in patients with early Idiopathic Parkinson's disease. PRESENTATIONS:
● Non-motor Symptoms in Parkinson’s Disease. Sponsored by Teva Pharmaceuticals and Medtronics. Chesapeake, VA. July 2012.
● Non-motor Symptoms in Parkinson’s Disease. Sponsored by Teva Pharmaceuticals. Norfolk, VA. April 2012.
● Role of a Nurse Practitioner and Current Clinical Trials at Ohio State University. Sponsored by Valeant Pharmaceuticals. Central Ohio Parkinson’s Society. Columbus, Ohio April 26, 2008
● Current Clinical Trials and Research Process. Roles of a research participant and Principal Investigator. Wallace-Kettering Neuroscience Institute. Kettering, Ohio. March 28, 2009
● Diagnosis and Treatment of Parkinson’s Disease. Sponsored by Teva Pharmaceuticals. Columbus, Ohio. February 20, 2008.
● Questions and Answers on Parkinson’s Disease and Current Clinical Trials at Ohio State University. Ohio University Athens Support Group. October 14, 2008.
● Questions and Answers on Parkinson’s Disease and Current Clinical Trials at Ohio State University. Knightsbridge Forum Support Group. April 9, 2009.
● Clinical Trials in Early Parkinson’s Disease for the Treatment Team, Virginia Beach, VA. June 2011.
PUBLICATIONS:
● Kieburtz, Karl, Pramipexole given twice per day has similar efficacy to an equivalent Dosage given twice per day. Manuscript. PSG. October 2009. LICENSES AND CERTIFICATION:
● CPR and ACLS
● Certified Clinical Research Professional
● Completion of CITI Course in The Protection of Human Research Subjects
● ACRP for research professional, Member
● Electronic Medical records certification
ACHIEVEMENTS:
● Phi Eta Sigma, honor society
● Alpha Gamma Delta, honor society
● Scarlet and Gray Scholarship
● Golden Key National Honor Society
● Senior Leader, The Ohio State University Soccer Club
● American Academy of Neurology, Member June 1997 — February 2001
Contact this candidate